Scripsamerica PE Ratio 2013-2015 | SCRCQ
Current and historical p/e ratio for Scripsamerica (SCRCQ) from 2013 to 2015. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Scripsamerica PE ratio as of August 26, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Scripsamerica PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2025-08-25 |
0.00 |
|
0.00 |
| 2015-03-31 |
0.12 |
$-0.01 |
0.00 |
| 2014-12-31 |
0.17 |
0 |
0.00 |
| 2014-09-30 |
0.09 |
0 |
0.00 |
| 2014-03-31 |
0.12 |
0 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.000B |
$0.000B |
|
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs. The Company is focused on pharmaceutical supply chain management services, from strategic sourcing to delivering niche generic pharmaceuticals to market. It delivers pharmaceutical products to a range of end users across the health care industry, including physicians' offices, retail pharmacies, long-term care sites, hospitals, and Government and home care agencies. The Company's therapeutic categories include pain, arthritis, prenatal, urinary and hormonal replacement drugs. ScripsAmerica, Inc. is based in Tysons Corner, Virginia.
|
